Arrowhead Pharmaceuticals(ARWR) - 2026 Q1 - Quarterly Report
Arrowhead PharmaceuticalsArrowhead Pharmaceuticals(US:ARWR)2026-02-05 21:06
Transcript

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 _____________________________________ FORM 10-Q _____________________________________ (Mark One) For the quarterly period ended December 31, 2025 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-38042 _____________________________________ ARROWHEAD PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) _____________ ...